Sanofi has extended its collaboration with Koneksa, a developer of patient-centric digital biomarkers for drug development, in central nervous system (CNS) clinical trials.   “We’re proud that our long-term partnership has enabled Sanofi’s deployment of digital measures across multiple therapeutic areas and modalities,” said Chris Benko, Koneksa’s CEO. “This project leverages learnings from our collaboration on Parkinson’s Disease into multiple scleros...